Skip to main content
logo
Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
40.53
+0.55 (1.36%)
Jan 22, 2026, 2:15 PM EST - Market open

Liquidia Revenue

Liquidia had revenue of $54.34M in the quarter ending September 30, 2025, with 1,121.72% growth. This brings the company's revenue in the last twelve months to $69.22M, up 343.41% year-over-year. In the year 2024, Liquidia had annual revenue of $14.00M, down -19.97%.

Revenue (ttm)
$69.22M
Revenue Growth
+343.41%
P/S Ratio
49.36
Revenue / Employee
$407,153
Employees
170
Market Cap
3.53B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202414.00M-3.49M-19.97%
Dec 31, 202317.49M1.55M9.75%
Dec 31, 202215.94M3.08M23.98%
Dec 31, 202112.85M12.11M1,637.77%
Dec 31, 2020739.63K-7.33M-90.84%
Dec 31, 20198.07M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Corcept Therapeutics741.17M
Arcutis Biotherapeutics317.93M
IDEAYA Biosciences214.83M
Viridian Therapeutics70.79M
Beam Therapeutics55.70M
NewAmsterdam Pharma Company35.24M
Centessa Pharmaceuticals15.00M
Xenon Pharmaceuticals7.50M
Revenue Rankings

LQDA News

More News